# Deisseroth, Hegemann and Nagel Win 2026 Nobel Prize in Medicine for Optogenetics The 2026 [[wiki/Nobel Prize|Nobel Prize]] in Physiology or Medicine was awarded on October 5, 2026, to American Karl Deisseroth, 54, of Stanford University and Germans Peter Hegemann, 71, of Humboldt University in Berlin and Georg Nagel, 73, of the University of Wurzburg, for "discoveries concerning light-gated ion channels and [[wiki/Optogenetics|optogenetics]]." The announcement from the Nobel Assembly at the [[wiki/Karolinska Institute|Karolinska Institutet]] in Stockholm opens the annual Nobel week. The three laureates share 12 million Swedish kronor, about $1.2 million, and will receive the prize at the formal ceremony on December 10. The work began in the 1990s, when Hegemann - then at the Max Planck Institute for Biochemistry - investigated how the single-celled alga Chlamydomonas swims toward light and identified a light-sensitive protein behind the behavior. With Nagel, then at the Max Planck Institute for Biophysics in Frankfurt, he showed that the protein acts as a switch: illuminated, it opens a channel that lets ions flow through it. They called it channelrhodopsin - "the switch neuroscientists had long dreamed of," as Nobel committee member Abdel El Manira put it at the announcement. In 2003 the pair reported introducing the protein into human and hamster cells to generate electrical impulses with light; in 2005 Deisseroth showed it could control nerve cells in living rats, and the method was named optogenetics in 2006. The committee's summary of what the method achieves: it "makes it possible to switch on, or off, the activity of individual nerve cells in a living brain." It is now used in laboratories around the world to map the neural circuits behind memory, feeling, and behavior relevant to neurological and psychiatric disorders. Clinical translation is already underway. Researchers are using optogenetic methods in attempts to restore vision in people with visual impairment, and teams including Tobias Moser's at the University of Gottingen are developing optical cochlear implants - light emitters paired with light-responsive cells - aiming for clinical trials in 2026, seeking finer spectral resolution than conventional electrical implants can deliver. Nagel himself sounded a note of restraint at the announcement, noting he knew of only one patient who had benefited from optogenetics so far and that he had considered the medicine prize "still too early." The physics prize follows on Tuesday, with chemistry, literature, peace, and economics to come through the week. ## Related topics - [[wiki/Optogenetics|Optogenetics]] - the light-gated control method the prize recognizes - [[wiki/Magnetogenetics|Magnetogenetics]] - the magnetic counterpart to optical neural control - [[wiki/Brain-Computer Interfaces|Brain-Computer Interfaces]] - the clinical interface layer optogenetics is entering - [[wiki/Nobel Prize|Nobel Prize]] - the award and its physiology-or-medicine lineage ## Related articles - [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] - the state of neural interfaces in the year optogenetics won the prize - [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] - the auditable dependency graph for person-scale continuity across substrates ## Sources - [Reuters](https://www.reuters.com/business/healthcare-pharmaceuticals/deisseroth-hegemann-nagelwin-2026-nobel-medicine-prize-2026-10-05/) - [New Scientist](https://www.newscientist.com/article/2591980-nobel-prize-for-medicine-goes-to-trio-who-developed-optogenetics/) - [Associated Press](https://www.kdlg.org/as-heard-on-npr/2026-10-05/nobel-medicine-prize-goes-to-3-scientists-for-research-into-brain-activity) - [IEEE Spectrum](https://spectrum.ieee.org/cochlear-implant)